InvestorsHub Logo
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

Re: jimmy667 post# 3730

Saturday, 09/01/2018 9:25:50 PM

Saturday, September 01, 2018 9:25:50 PM

Post# of 5001
Jnj has deeper pockets. If jnj wants vtgn they will get vtgn over sage. I see av101 has complimentary to esketamine. The question is, if av101 shows strong efficacy as a mono therapy, what price would jnj, maybe agn or another cubist have to pay for vtgn? $100? Can’t see vtgn staying independent

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News